SCHEMBL6982469

SCHEMBL6982469

CC(C)n1nc(-c2cc(Oc3ccccc3)nn2-c2ccccc2)ccc1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
TSHR P16473 1/20 0.38
BCL2 P10415 2/20 0.38
MDM2 Q00987 2/20 0.38
MCL1 Q07820 2/20 0.38
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
HTT P42858 1/20 0.36
ALDH1A1 P00352 4/20 0.36
KMT2A Q03164 2/20 0.36
ATM Q13315 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
MGLL Q99685 1/20 0.36
GAA P10253 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6986812 0.88 ALDH1A1 (0.40) SMN1; SMN2TSHRBCL2MDM2MCL1
SCHEMBL6985846 0.87 BCL2 (0.41) SMN1; SMN2TSHRBCL2MDM2MCL1
SCHEMBL6983706 0.87 HTT (0.36) CYP2C9SMN1; SMN2TSHRHTTALDH1A1
SCHEMBL6987183 0.85 TSHR (0.45) SMN1; SMN2TSHRBCL2MDM2MCL1
SCHEMBL6979346 0.85 ALDH1A1 (0.41) CYP2C9SMN1; SMN2CYP1A2CYP2C19TSHR
SCHEMBL6987419 0.83 ALDH1A1 (0.43) SMN1; SMN2TSHRHTTALDH1A1
SCHEMBL6989950 0.82 CYP3A4 (0.35) CYP2C9CYP1A2CYP2C19TSHRHTT
SCHEMBL6987971 0.81 HTT (0.38) SMN1; SMN2TSHRHTTALDH1A1
SCHEMBL6986605 0.81 HTT (0.48) SMN1; SMN2TSHRBCL2MDM2MCL1
SCHEMBL6983312 0.81 HTT (0.37) SMN1; SMN2TSHRHTTALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313733-A1 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-05-28 EP disclosed
WO-2002018382-A1 PYRAZOLOPYRIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-07 WO disclosed